Intrinsic factors of CAR-T cells may play a major role in their clinical success

The development of CAR-T technology in recent years has been a major milestone in the fight against cancer. These sort of “living drugs”—T-cells modified to expand, recognize and attack cancer cells within the body—offer hope to many patients after relapse or failure of the standard treatment…
Read More